DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Von Minckwitz G, Eidtmann H, Rezai M et al.
Neoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancer.
N Engl J Med 2012;
366: 299-309
Access:
We do not assume any responsibility for the contents of the web pages of other providers.